Tell us a bit about the institution/company/organisations you work for. For the last twelve years, I’ve been working at Aridhia (https://aridhia.com), an SME based in Edinburgh and Glasgow specialising in informatics for biomedical research. After working for some years with specialist clinicians in hospitals and clinics with specialised medical data, we found our current focus…Details
The worldwide COVID-19 pandemic has inevitably impacted EPAD and its consortium members. The EPAD project management team is monitoring the situation closely. Most EPAD research and clinical trial activities had to stop as of early March as progressively universities across Europe closed, and the clinical sites were either closed or saw site staff redeployed to…Details
What is your current role in EPAD? My current role in EPAD is the PI of the EPAD Bioresource. This is the sample collection that has been taken from EPAD participants from across Europe and is held at the University of Edinburgh. The Bioresource is responsible for the safe storage of these samples and for…Details
The EPAD consortium wishes to congratulate Lisa Vermunt and Lucy Stirland, two EPAD fellows, on successfully defending their PhD thesis in March 2020. It was two great days and we are proud of their contributions and all the hard work that Lisa and Lucy have put in – very well deserved! We wish them both…Details
A message from the EPAD Coordinators to all involved in the EPAD Longitudinal Cohort Study By now you will all be aware of the unexpected closure of the EPAD Longitudinal Cohort Study. We are writing to you to explain the background to this and also to thank you for your commitment to this research and the…Details
EPAD publishes a paper on the cognitive functions as predictors of Alzheimer’s disease biomarker status
The EPAD team published a new paper entitled “Cognitive Functions as Predictors of Alzheimer’s Disease Biomarker Status in the European Prevention of Alzheimer’s Dementia Cohort” in the journal of Alzheimer’s disease. Abstract: Alterations in Alzheimer’s disease (AD) biomarkers have been observed decades before the onset of dementia. Cognitive dysfunction, while central to the clinical diagnosis…Details
What is your current role in EPAD? I co-lead WP2 (Statistical/Methodology Engine Room) and I am also a member of the Balancing Committee that has important input in the selection of individuals into the EPAD Longitudinal Cohort Study. I have been involved in different roles in various publications using the EPAD data. Tell us a…Details
What is your current role in EPAD? I work as a clinical lead at IQVIA where I manage the clinical research associates (CRAs) across all the countries that contribute to EPAD. I provide clinical trial expertise in accordance with protocols and with ICH GCP (International Conference on Harmonisation Good Clinical Practice). As clinical lead, I…Details
With the beginning of this new year, the EPAD project is celebrating its fifth birthday.
We are proud to look back at a lot of successful deliveries. We list herein some of our key highlights of the past 12 months.
Wishing you all an exciting and happy New Year,
The members of the EPAD initiative are glad to announce that its Longitudinal Cohort Study has recruited its 2,000th research participant in Sheffield (UK) this 15th January. Congratulations to the EPAD team in Sheffield (pictured). “Since we joined the project last year, patients in our area have been enthusiastic about the opportunities offered to them…Details